India is a developing nation, and manufacturing the next generation of vaccines there has become a key challenge for the United States, where the country has a reputation for producing some of the world’s most toxic and ineffective vaccines.
But even with the United Nations calling on India to halt production of the highly toxic monovalent vaccine that has become the target of some of India’s worst outbreaks, the government is refusing to halt the supply of the vaccine to the country.
“I don’t want to see a vaccine in India that’s unsafe,” said Dr. Pratap Jha, president of the Indian Academy of Medical Sciences.
“We need to be sure of what’s going on in India before we start making vaccines here.”
India has been a source of controversy, especially because the vaccine it produces contains the same genetic material that causes a severe form of autism spectrum disorder.
The vaccine, developed by Merck and Sanofi Pasteur, is designed to help prevent the disease and has been used successfully in more than 200 countries, including India.
The disease is caused by a mutation in a specific protein that causes the immune system to produce antibodies to foreign substances, and the vaccine does not contain the protein, called vaccinia.
However, some Indian scientists have been concerned that the vaccine has not been tested for safety and that the country’s government is not testing the vaccine against the vaccine strain, which is responsible for the vaccine’s toxic properties.
India’s Prime Minister Narendra Modi has vowed to stop vaccinia production, but he has been unable to do so.
The United States has also been pushing to prevent the use of vaccinia-producing vaccines in India, arguing that the virus is a threat to human health.
The National Vaccine Access Coalition, a group of pharmaceutical companies, vaccine manufacturers and vaccine researchers, has been pressuring the Indian government to stop the production of vaccine strains that have a high risk of contamination.
In March, the coalition issued a statement saying that India “should not continue to produce vaccines that have been identified by the United Nation to be toxic and harmful to human and animal health.”
The coalition also said that the use and distribution of the vaccines is illegal and that “India must immediately halt the production and distribution to the Indian public of the monovalents produced by the vaccine manufacturing companies.”
India’s vaccine production is not only regulated by the countrys Food and Drug Administration, but also by the Ministry of Health.
In a statement issued on Monday, the ministry said it had taken the following steps to address concerns raised by the coalition: “We are now monitoring the situation closely and will take appropriate action if there are any concerns.”
According to a Reuters report published Monday, India’s Food and Drugs Administration is not yet in charge of ensuring the safety of vaccines produced in India.
“In this case, the regulator has taken no action,” the statement said.
India has said that vaccines made in India are tested to ensure that they are safe.
“The safety of the product is ensured by the approval of a safety certificate, which was issued by a laboratory,” the Ministry said in a statement.
However the government has not provided a copy of that certificate to Reuters, and it has not given any details of the safety testing that was conducted.
Reuters has reached out to the Department of Science and Technology of the Ministry, but has not received a response.
India is home to more than 150 million people, most of them poor and largely illiterate, who rely on the vaccine produced by Merkle, which manufactures the vaccine in several other countries, such as China and the United Kingdom.